{"id":249939,"date":"2026-09-16T17:25:26","date_gmt":"2026-09-16T11:55:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=249939"},"modified":"2026-09-16T17:25:27","modified_gmt":"2026-09-16T11:55:27","slug":"neuland-laboratories-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-bull-case-vs-bear-case-2026\/","title":{"rendered":"Neuland Laboratories Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n
\n

Neuland Laboratories Key Stats (16 Sep 2026)<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sector<\/td>\nPharmaceutical Active Ingredients (API) Manufacturing<\/td>\n<\/tr>\n
Current Market Price<\/td>\nRs 22,520.00<\/td>\n<\/tr>\n
52 Week High \/ Low<\/td>\nRs 24,225.00 \/ Rs 11,500.00<\/td>\n<\/tr>\n
Market Cap (Rs Cr)<\/td>\n28,897<\/td>\n<\/tr>\n
P\/E Ratio (Industry P\/E)<\/td>\n58.05 (37.96)<\/td>\n<\/tr>\n
Return on Equity<\/td>\n19.42%<\/td>\n<\/tr>\n
Debt to Equity<\/td>\n0.16<\/td>\n<\/tr>\n
EPS (TTM)<\/td>\nRs 387.98<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.15%<\/td>\n<\/tr>\n
Book Value<\/td>\nRs 1460.31<\/td>\n<\/tr>\n
14 Day RSI<\/td>\n39.62<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Quick Answer<\/strong><\/p>\n

The Neuland Laboratories bull case rests on exceptional return on equity, while the bear case points to sharp single session rally but off highs. At Rs 22,520.00, the stock sits between its 52 week low of Rs 11,500.00 and high of Rs 24,225.00, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Neuland Laboratories bull case against the risks yourself.<\/p>\n<\/div>\n

Neuland Laboratories<\/a> operates in the pharmaceutical active ingredients (api) manufacturing space, and its shares currently trade at Rs 22,520.00, placing the stock within a 52 week range of Rs 11,500.00 to Rs 24,225.00. For anyone building or reviewing a position, the Neuland Laboratories bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.<\/p>\n

Rather than pushing you toward one conclusion, this Neuland Laboratories bull case analysis sets out what the bulls see in Neuland Laboratories shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Neuland Laboratories bull case thoroughly, alongside its counterpart, is essential before making any investment decision.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n